Expert Interview
Discussing the potential of the Optilume Benign Prostatic Hyperplasia Catheter and Balloon system from Urotronic and how it compares to medications from Merck, GSK, and Astellas.
Ticker(s): UROTRONIC, ALPMY, MRK, GSKInstitution: Montefiore Medical Center
- Associate Professor of Urology at Montefiore Medical Center
- Manages 100 patients with BPH
- Clinical interest in prostate cancer screening
Describe your background and practice setting
Added By: ben_adminHow many patients with BPH do you manage?
Added By: ben_adminWhat is your opinion on the Optilume BPH catheter and balloon?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
